DatasetName,CEP135_S(1035) CEP135_S(1132) CEP135_S(21) CEP135_S(3) CEP135_S(438) CEP135_S(439) CEP135_S(441) CEP135_T(1116) CEP135_T(156) CEP135_T(488),CEP135_S(1130) CEP135_S(1134) CEP135_S(253) CEP135_S(356) CEP135_S(383) CEP135_S(668) CEP135_T(1121)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.445550571595542,0.5333101590513969
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.4638390958707819,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.4576557960974893,0.5654435870535401
RKK2015_TNF-α/basal,,0.556587070639714
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,0.5455299360191942
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.46872665751636466,0.574637039179325
JW2015_Intensity pre1,0.46329011103727086,
IMM2018_normalised rep. int. Empty-3,0.46134365790849274,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.4677716994930832,0.5844941422310644
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5557942799886847
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.462588269904369,0.5606206824695785
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.4611787164141868,0.5493263833582783
FSO2013_Ratio M/L normalized Rep1___1,0.46803338461857835,0.5843004361841057
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.42602332169025636,0.5563472585545588
WZ2023_Pu_010_30min,0.43263471946955673,0.5568981635375224
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.4610920421813596,0.5616678807784939
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.4478333604773854,0.5670684183016657
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.4324297591782774,0.5360532768151304
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.435841844979959,
AH2018_SILAC_MR_2_N,0.4581338600366115,0.5388357929870954
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),0.4437186426626055,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.4531693008289614,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.44406761629323704,0.5707105434048078
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4523709923110483,0.5542625134139719
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.46273411083015636,0.5605384880750759
KBE2022_Log2_Ex_34_U,,0.5626795665784623
WZ2023_Pu_005_10min,0.4446108692323404,0.5577839625378124
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.4456132112732029,0.5573088911116411
AH2018_SILAC_MR_2_X,0.4629713481651356,0.5621930182272158
HS2024_4_PD_T2,0.46684099013643693,0.5471726957404
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4644909539670533,0.5867054808535312
FR2021_Norm.Intensity.B,0.4574025080619615,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.46352645301646855,0.5925277917706373
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.4680987623532752,0.5605747812134779
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.46884195434292913,0.5487522562218291
HS2024_7_PD_T2,0.47899468997659367,0.5487814156979616
FSO2013_Ratio H/L normalized Rep1___1,0.4686630458917184,0.6061905312828441
AH2018_LFQ_1_C,0.4517203141118308,0.5557680364372135
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.44982791183513654,
HS2024_3_B_N1,0.4632679104417633,0.5562137645368338
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.45103989449549575,0.5576279193686158
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.4684647878425925,0.5471517103771052
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.45933123907892054,0.5539180918176191
FSO2013_Ratio H/L normalized Rep2,0.47730446726829223,0.582054981653701
WZ2023_Pu_005_20min,0.4383728493779341,0.5592770272635198
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4628144676184694,0.5795584862899901
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.4593403840559122,0.5658141410759623
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.455839810099519,0.5630120934604064
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.466403967972732,0.5898225734036523
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.45905863999321683,0.5677949459510488
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.44766303108398625,
FR2021_Norm.Intensity.H,0.46192909429559625,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.46497752013067933,0.5575959086880318
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5557849084195131
PG2020_Intensity Mock_10h_D,0.43936115310145735,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4503640547864743,0.5603720616369642
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.45113046758499487,0.5688442924460612
RCJD2014_5min_1,0.45923882180513464,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.5487361149375768
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.46339993441399807,0.5594724260211105
PG2020_Intensity 2h_C,0.4476283192783936,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.45011319463865024,0.5575278859478527
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.4725875039044055,0.558791653628403
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.4627268630994192,
HS2024_5_PD_T1,0.4546489724415367,0.5843714209737376
AH2018_LFQ_M_2_C,0.45370522675944425,0.5684727688560479
CK2022_3 40-1,,
RBK2021_1260T Early,,0.5540587080224637
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.4503998519921482,0.5476384675457701
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.4549726586914688,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.4662647937318452,0.5425409391227921
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.46003076483407923,0.5553853934487969
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.46737291884633547,0.5637383387371291
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.4799071354629697,0.5692384246132746
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.461478768289098,0.5233755353981631
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,0.5560279310685463
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.46453221401688377,0.5521328307066644
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.44239032859896665,0.5696159141269532
DL2023_12h-2,,0.5444557800271889
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4419604987562703,0.5565555339655343
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.5527610413539188
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.4614936116528396,0.5688255179507503
FSO2013_Ratio H/M normalized Rep2,0.4705985775802889,0.5625919119247196
RAM2015_Log2 A,0.459258239328552,0.5559182413404746
HS2024_8_PD_T1,0.44652454521800405,0.560628380529316
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.45917139086884873,0.5515218337260231
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.45198240549583446,
HS2024_7_I_T1,0.4554565072620392,0.558551209583514
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.46219657992074775,0.5548434859823479
AH2018_SILAC_M_3_X,0.46856327837690814,0.5617724448804975
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.44866164665546426,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.45375632893464396,0.5452746780012355
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.4623296165324725,0.5630296329151305
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4270888184664791,0.5572518860510605
HS2024_6_B_N1,0.45678577503112716,0.5652382979599401
KBE2022_Log2_Ex_27_T,0.45132616407558734,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.45647101837290693,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.4532430204482618,0.5421717234314947
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.45248515441189296,
FSO2013_Ratio M/L normalized Rep2,0.4459843225203546,0.5727725790644694
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.46572968361786415,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.4451682795533406,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.45125150162783967,0.5499005326501187
DL2023_control-1,,0.5308836842399695
AR2021_ALG 10 μM,0.47526957671306597,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.45619186464309136,0.5597790160374971
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.5766323381356401
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.4663066835319885,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.4525057890306036,0.5696630596095312
JW2021_After_3,0.45118162594499456,0.5608123308717816
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.46800595852256704,0.5469068137592991
CK2022_11 200-1,,0.5599048491103459
CK2022_12 200-1,,0.5599255311353328
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.4601462269443216,
WZ2023_Su_010_20min,0.4400144403416517,0.5590109308752284
AH2018_TMTMS2_2_N,0.43587169149187355,0.54251799281135
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5601654389057533
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.45879907438009904,
AH2018_TMTMS3_Pool,0.4617461098476131,0.5412583406611164
KS2014_Intensity N4,0.46382734880153925,0.5648094935061855
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.5585745092317062
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.460295662217988,0.540894110878762
AST2020_anti-CD3+PDL2.2,0.4624976401396407,0.5623369299878744
PG2020_Intensity Mock_10h_A,0.448501122875611,
JW2021_After_2,0.4488377943962762,0.556919674456154
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.47275327386856264,0.5659818440538984
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.45430663544849076,0.5589244434052009
CF2017_EOC 1,0.42896667604713024,
CK2022_3 200-1,,0.5566582635358316
AH2018_LFQ_IT_3_C,0.4679526692551895,0.5502502653923732
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.4530417246435158,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.44926268580364354,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.4528238740032151,0.553407865812379
HS2024_5_B_T1,0.4932532602465689,0.5763848786993284
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,0.5387002826127605
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.46177371359035374,0.5599829064451376
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5558469813145815
JW2021_Before_2,0.47147944699534106,0.563944011137025
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.5793130480219381
HS2024_4_B_T1,0.460241320230776,0.5546159507730409
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.47582274339072494,
CR2017_Ratio Replicate 3.2,0.46014471239770083,0.5866849944547482
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5584273758858985
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4407600357211009,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5581978678474331
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5596614737578177
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.46837255076521284,0.5469985093127138
HS2024_5_PD_T3,0.4681904351089746,0.5767485805832474
AH2018_TMTMS3_3_X,0.4651096579765069,0.5461662503567456
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.45082294182186133,0.5616410545097679
AH2018_LFQ_M_1_N,0.4578225305700611,0.5321852991987269
KBE2022_Log2_Ex_27_U,0.4500790436995601,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.46218386074858236,0.5809521463287867
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.4481662705181573,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.5380085476796838
LG2023_Control-1_intensity,0.44260062335843753,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.45045489080938284,0.5498054523374213
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.472303675719336,0.5695074669562539
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4647503995990313,0.5513571221956811
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.47328694346258865,0.5682327054553981
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,0.4409895036870596,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.44090100955387534,0.5395595312065227
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.43919064197924484,0.538821809925924
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,0.4400548455727026,0.5639013547320925
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.44881325240680897,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.4629942080119346,0.562406485711384
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.4595971218571921,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.44618577570630336,0.5719254049240965
LG2023_Control-2_intensity,0.430936952290613,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.4517901177163187,0.568378942154996
AH2018_LFQ_1_X,0.45809676941292493,0.558312832416546
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.4490585796978439,
FR2021_Norm.Intensity.M,0.4593282403174454,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.47135756339473367,0.559799090748142
HH2022_Reporter intensity 1,0.4659200657676397,
HH2022_Reporter intensity 2,0.46455310974463015,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.44996757336276005,0.5630877390766444
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5159175692525688,0.5810980660381865
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4559034123112613,0.5843935444229681
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.467841636862545,0.5618278121893711
AR2021_KD 72h,0.46385782297756284,0.5529092502786711
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.447227004106308,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4647951281197179,0.5483028320353415
KBE2022_Log2_Ex_9_U,0.44914601566637635,
AH2018_SILAC_M_3_N,0.4678946332846265,0.5647276644131084
KBE2022_Log2_Ex_13_T,0.4511639644647384,0.5606745033222428
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.4432911125232941,
CF2017_OSE 29,0.44821988858653244,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,0.5496023307940054
HS2024_7_B_N2,0.4660976988705454,0.5446827300407399
PG2020_Intensity 10h_A,0.45626670898066324,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.4667943159009572,0.5641313025928841
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,0.4577946390020503,
FSO2013_Ratio H/M normalized Rep1___1,0.4715253165563785,0.56293063967323
JW2015_Intensity cap2,0.457827296664408,
BS2014_Log2(Ratio H/L normalized Rep_2),0.4582958274201118,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,0.5876832764075781
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.44358178683844274,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.5579131431769576
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.45326638102961025,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.4818726281620048,0.5772060773379446
CK2022_7 200-1,,0.554997623930947
CK2022_5 200-1,,0.5556630196567759
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.4775464529191577,0.5828799687971483
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5576807391505267
AH2018_SILAC_MR_1_X,0.44996777315321834,0.5658159700312873
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.4631413376360677,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.5526427862072052
AH2018_SILAC_3_C,0.46680619417479036,0.5641970811472443
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.4694954279650704,0.5587812542359825
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.45157085730695623,0.5161081616516989
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.4549288413365143,
FSO2013_Ratio H/L normalized Rep3,0.4709836892077619,0.54590843495686
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.44486340846875166,0.5415339964686225
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.4612722876986649,0.5563842954979916
KBE2022_Log2_Ex_9_T,0.4557767714977568,
AH2018_SILAC_IT_2_N,0.45664450269062673,0.5566007504389272
AH2018_SILAC_IT_1_X,0.45269367309400577,0.5563954405117119
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.4778119561988676,0.5440694423079849
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.4531834592832434,0.5557842072462785
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.45410324698534266,0.5453606472553643
HS2024_4_I_N2,0.4984138782392848,0.5729090414147426
AH2018_TMTMS2_3_N,0.44042722955283403,0.5421911882009997
RN2012_H06,,0.5903713641677346
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4767475590611433,0.5492509008860668
WZ2023_Su_005_30min,0.4439324926040065,0.559901852615454
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.4703036950360685,0.5459456227886036
WZ2023_Su_025_10min,0.4433321320650789,0.557803675141046
AH2018_LFQ_IT_4_X,0.46809582304094477,0.5604926345626827
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.43704608930912653,0.5593513510019981
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.4421169065754544,
EP2017_Pervanadate R#1 log2 ratio,0.44028958676527674,0.5685895484396368
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.45542691076461034,0.5612356740751091
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.44348912928549755,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.4792394971452887,0.5572898859403896
RN2012_L10,,
PG2020_Intensity 4h_C,0.42982954799417056,
EP2017_Mitotic R#3 normalized log2 ratio,0.4454626960321468,0.5693419780060559
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5591903892722351
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.45406209940945985,0.5537001222703228
HS2024_4_B_T3,0.466860710595672,0.5505116964344756
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.4514960764430935,0.5426137926740232
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.44720087297184213,0.5490240204791635
KBE2022_Log2_Ex_6_U,0.4539537443484881,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.4571037863391433,0.5819359296608637
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5584360505963094
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.43927600026077956,0.5715375509106162
GF2025_P9_Sph,,
CK2022_6 200-1,,0.5550255627182146
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.46368226771764476,0.5504260157718628
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,0.4608158578767766,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.460528973632889,0.5530089600755773
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.46751684385204284,0.5417269297440265
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.4647956000668498,
HS2024_3_B_T3,0.4790827510571695,0.5590679452526345
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.4496569824429687,
EP2017_Untreated R#3 normalized log2 ratio,0.46978707884734555,0.5448435240689585
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5552395191000011
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4581883595590863,0.5702508418971448
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4370166683183947,0.5732425729290421
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.4680228812425235,0.5504041930223307
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.4639175327286866,0.5566688591692702
KBE2022_Log2_Ex_29_T,0.4522381252021351,
HS2024_7_I_T2,0.4853581557980949,0.5527724012572058
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.47513592060337667,0.5658439169195183
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,0.4593282403174454,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.4498589034111962,0.5132732322015736
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.45873134690570205,
PG2020_Intensity CT_C,0.4444883003563699,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.45169939260011427,
EP2017_Untreated R#3 log2 ratio,0.47218045474926873,0.5458954349577665
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4601756504518456,0.5460958796743057
HS2024_8_PD_T2,0.43877123948653923,0.5573605757735044
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.4606500831076105,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.4500138827346367,0.5461472208185147
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.4513394441888973,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.5577923521378781
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.46173516882605564,0.5733144900588008
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4681520670539844,0.5448339486550743
HS2024_3_PD_T3,0.46837469226955425,0.5550058885008311
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.4625222039981309,
RAM2015_Log2 C,0.4801408360103692,0.5511488634567363
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.4556627660920773,0.5506744585180658
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4475285018138272,0.5628897292472692
CK2022_2 16-1,,
RAM2015_Log2 B,,0.5528924023719022
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.46449618426167855,0.576471904179919
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,0.45320680115365297,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.45184080978406727,0.5478776872505817
PG2020_Intensity Mock_10h_B,0.44101070058533676,
WZ2023_Su_025_30min,0.4410277176879213,0.5569679877417842
AH2018_LFQ_4_N,0.45344163451219177,0.5172045180629156
CR2017_Ratio Replicate 1.2,0.4623369145762132,0.5682314305761842
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.4572110377526898,0.5378794389098676
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.44517841938700115,
AH2018_SILAC_M_1_X,0.4630161178180595,0.577638201434239
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,0.5335175484010218
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.4728302130015902,0.5699397564103951
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),0.4472191668479509,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.45823335072147175,0.5419449676952692
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.46009666728382614,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.4547723240543927,0.5512434992002142
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.46004801442100207,0.5366138336902262
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.45214063170595303,
AH2018_LFQ_2_X,0.4545937782694566,0.5623290267102746
PG2020_Intensity 2h_B,0.449144406338957,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.45942819675529856,0.5554754139707381
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.45766919767798164,0.5654196193195783
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.45476360433579843,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.45594652743420755,0.5606765449374744
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.45453989142517387,0.5477856937730656
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,0.4501468265781517,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5855018824793886
AH2018_LFQ_3_N,0.4484357610936252,0.5604888668763379
RKK2015_TNF-α/IKKb,,0.5673614614536493
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.4541481133216297,0.554819713912928
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.452972948008029,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.45220408995504846,0.5836940269727683
WZ2023_Su_025_20min,,0.5579261989066852
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.46519782173629903,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.466070586068173,0.6018015866812683
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.4499916559842042,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.4683644181551999,0.5629685512589472
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.4488158115176695,0.5718588496702263
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.4365571184251363,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.45332389001319584,0.516535472525788
AH2018_LFQ_M_4_C,0.45870880466843555,0.5335377620813926
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.5496702040272604
MV2014_Ratio L/M normalized B2___1 (30 min),0.45670870475855063,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5638096962703599
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4542791823900324,
LY2019_P3-,,
FR2021_Intensity.A,0.45604887701798624,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4538463049784872,0.5581159892394979
HS2024_8_PD_T3,0.4647121608361634,0.545203102598673
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.4625746474400419,0.5620144958111035
JW2015_Intensity cap1,0.4575425653132418,
PG2020_Intensity CT_A,0.44780773141342467,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.44256639326255653,0.5552895011482942
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,0.45850021238495736,
HS2024_5_B_N1,0.44453878960698867,0.5689720496185793
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.44227324078539043,0.5423242656226023
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.4678398490496445,0.5513867033613805
HS2024_8_I_N2,0.4509577017476201,0.5330659286943399
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.4603628701705967,0.5826330067322761
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.4566072777805476,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.4614153162173572,0.5394172086831799
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.44618067422243446,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.46230939854357944,0.5642669383833039
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4528180488521505,0.5575334321997651
AST2020_Control.2,0.4624181546079515,0.5627811050753911
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.46353283080054314,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.4796552329539203,0.5827282643651427
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.4885406321598274,0.5783257921310161
HS2024_6_I_T1,0.4819581252501413,0.5683967685555608
HS2024_5_B_T3,0.4642807876046187,0.5773482869313493
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.4481905901375005,
AH2018_TMTMS3_3_N,0.4683605140167556,0.5479236346347008
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,0.4584917138034671,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.45273461559745937,0.5671565892766175
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4523396368247525,0.5721991508654217
KBE2022_Log2_Ex_36_T,0.4519499225768736,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.44711131005558713,0.5579980236037805
KS2014_Intensity C2,,0.5395218082213737
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4515061188458894,
CK2022_9 200-1,,0.5585574424390211
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5585681118020253
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.4519475017773923,0.5511224638192783
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4545407261205049,0.5503022672802814
HS2024_3_I_T3,0.47812036386006473,0.5556323972863285
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.46250112283786377,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.4487273472179968,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.481376671733015,0.5583421143375882
RKK2015_SC-514/basal,,0.557003253923652
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5570636528333427
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.44201749065278995,0.5609294942944716
KS2014_Intensity N1,0.4656972362410773,0.5650819600969151
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4582127160152031,0.57765412991583
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.4623213417379167,0.5612644376169031
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.44723709616082685,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.44876582082392097,0.5686812372475181
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.4557805675309215,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.47178974018789716,0.5614077121992251
HS2024_5_I_N1,0.4761569418579728,0.5515176012475029
HS2024_6_I_N1,0.458493238056244,0.5682991304056616
AR2021_KD 48h,0.4630239857555279,0.5322561617072905
FR2021_Intensity.B,0.45738624698677166,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.4506391277253757,0.547600089073917
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.463112527407125,0.5619988238551202
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.45190985369485065,0.5566174392318125
KBE2022_Log2_Ex_29_U,0.45259364460521045,
HS2024_7_B_T1,0.45728585671958843,0.5569547444191368
AH2018_LFQ_M_2_X,0.45807308235678734,0.5521418304888633
AH2018_LFQ_IT_4_N,0.4673732460460844,0.5636327579221502
CK2022_15 200-1,,0.5601438096964831
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.5613081274638758
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.5572486363978859
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.43686108793832756,0.5582832541793906
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.43659436676940466,0.5673780869023449
HS2024_8_B_T3,0.4568679329480899,0.5574878931031636
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,0.5577742862615614
WZ2023_Pe_010_20min,0.4521308134897989,0.5581908619783629
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.452821511228375,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.4480751468170595,
KS2014_Intensity C1,0.4551628937545599,0.5391842836326025
FSO2013_Ratio H/M normalized Rep3___1,0.4679714769697565,0.5620628829952342
AH2018_SILAC_M_3_C,0.46738592228336523,0.5652524212047634
RKK2015_TNF-α+IKKb/TNF-α,,0.5481256323248557
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.4688461501584906,0.5521408077934213
AH2018_SILAC_M_2_X,0.46738664673082475,0.5448772635961213
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.45660160834107116,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.44098040994978344,0.5583736637494957
PG2020_Intensity 6h_C,0.44417337317267275,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.4554054544801599,0.5243274744546074
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.4430079481620298,0.5437253507038785
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.45927102786841606,0.5549702757758059
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.45905024065023303,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,0.4645465601622402,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4456111227157301,0.5738813223500631
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.45777575765769124,
AR2021_L41 10 μM,,0.5456624197598651
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.46150569720487794,0.5688262144510103
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.4739783236911549,0.5543747690545494
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.45435351421260084,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4650376415505094,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,0.46081224751187194,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.4338241563726008,0.5406364844200541
AR2021_L41 1 μM,,0.5522718115481469
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.433046894862505,0.5381938066785287
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.46445355147793943,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4439966837229152,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.4602963281887965,
MV2014_Ratio H/M normalized B2___1 (5 min),0.44870578198810723,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,0.4628746017220645,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.454805648307116,0.5637116848958811
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.45771326571016296,0.5283643162593726
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.4541392264150462,0.5686902136999268
WZ2023_Pu_025_10min,0.44426545812756324,0.554912797187453
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.47633471947855444,
FSO2013_Ratio M/L normalized Rep3___1,0.44552616281755036,0.5331268011149121
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4546912979519955,0.5573367948812109
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.4679143148790317,0.5467000056972566
KS2014_Intensity C6,0.44365895969984714,0.5564963383669626
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.4553234296322393,0.5656987631298794
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.45533695679818376,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.4712134726209601,0.5463490783987756
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.46052708333174197,0.547652804390681
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.4628781798013886,0.5700220238101499
PG2020_Intensity CT_B,0.4425461396889812,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.4514695658854788,0.549796237777791
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.47510599727630787,0.5667881517130379
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.4799065193274494,
AH2018_LFQ_3_C,0.4607462511548504,0.5667399396505678
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.45347578832698393,0.5124578985950087
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,0.4689041371248548,0.559663112095264
KBE2022_Log2_Ex_25_T,,0.5516017312410448
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,0.46192909429559625,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.4628772549115644,0.5609468617319325
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.44532025317357143,0.5499302218338507
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.4492690054703231,0.5815399176885757
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4563691902216722,0.571092017024668
AH2018_TMTMS2_1_X,0.4341706765930387,0.5355016488684854
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.4558440414673388,0.5721380735901035
HH2022_Reporter intensity 4,0.4425484381166867,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.48577092048917186,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.40661097725530304,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.4608027230464729,0.5503858252578364
AH2018_SILAC_1_X,0.46232481831203504,0.564257541982438
PG2020_Intensity 10h_B,0.4562388193842633,
AH2018_TMTMS3_1_X,0.44929947888882743,0.531449359210234
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,0.5653255274500654
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.44399654798810956,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.4546700641959899,0.5609550388995975
EP2017_Untreated R#2 normalized log2 ratio,0.513905546093141,0.5799733647941109
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.45855999406481923,0.5663993883600525
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.44230297044632055,0.5743253254029937
AS2011_Ratio H/L Normalized RNAi_2_1,,
